Image for Voyager Clinical Trial

VOYAGER

A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

University Health Network encompasses the Toronto General and Toronto Western hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and The Michener Institute of Education at UHN. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.

Ontario, Canada Clinical Trial Location

University Health Network
101 College St, Toronto,
ON M5G 1L7, Canada